Moberg Pharma AB (publ) (STO:MOB)
Sweden flag Sweden · Delayed Price · Currency is SEK
9.33
-0.04 (-0.43%)
Jul 24, 2026, 5:19 PM CET

Moberg Pharma AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
14.5913.549.81-0.21-
Revenue Growth
13.47%37.99%----
Gross Profit
8.377.686.32-0.21-
Operating Income
-25.04-27.32-324.83-27.46-20.23-19.73
Net Income
-25.73-20.8-385.84-21.09-15.717.49
Earnings Per Share
-0.55-0.58-6.74-1.33-2.071.70
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
230.95230.95293.2960.56125.55102.66
Total Debt
2.552.554.144.746.113.93
Net Cash (Debt)
228.4228.4289.1555.82119.4598.72
Net Cash Growth
-21.01%-21.01%418.02%-53.27%20.99%-20.14%
Net Cash Per Share
4.744.747.431.5715.4122.37

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-12.23-17.49-16.47-33.21-16.84-15.3
Free Cash Flow
-12.23-17.49-16.47-33.21-16.84-15.3
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
57.38%56.73%64.37%-100.00%-
Operating Margin
-171.63%-201.77%-3310.88%--9771.01%-
Pretax Margin
-151.18%-177.41%-3266.48%--9426.09%-
Profit Margin
-126.04%-153.64%-3932.70%--9426.09%-
FCF Margin
-83.82%-129.18%-167.87%--8136.23%-

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----20.34
Forward PE
-91.9091.9091.9091.9091.90
PS Ratio
30.0536.2948.40-734.41-